Moleculin Biotech, Inc.
- Last sale
- Nov 12, 2026 · -0.18%
- Market cap
- $8.71M
- 1.06M shares
- Filings
- 846
Q3 2026
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2021N/M FY21 yoy
Q3 2026+107.5% FY25 yoy
- $8.71M
- —
- —
- 0.6×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $0 | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported |
Pharmaceutical preparations
Moleculin Biotech, Inc. is the 421st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
INBPIntegrated Biopharma Inc$43.9M19.3%6.5%$9.1MAEMDAethlon Medical Inc———$8.8MRKTORocket One Inc.———$8.8MMTVAMetaVia Inc.———$8.8M
MBRXMoleculin Biotech, Inc. (this company)$0.0——$8.7M
CALCCalciMedica, Inc.———$8.6MCURXCuranex Pharmaceuticals Inc———$8.4MGTBPGT Biopharma, Inc.———$8.3MVTGNVistagen Therapeutics, Inc.$1.3M161.1%5,491.3%$8.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Moleculin Biotech, Inc. · CIK 1659617 · Engraved from SEC EDGAR